According to the Center for Medicare & Medicaid Services, one major goal of health reform is to “lower health care costs through better health care quality.” Improved quality can take many forms-one of them is greater use of simple, low-cost, cancer screening tests, like mammograms. Researchers at PHAR, LLC, the UCLA Center for Surgical Outcomes and Quality, and RAND developed a framework to assess the cost-effectiveness of improving compliance in the US with the Healthcare Effectiveness Data and Information Set, a comprehensive set of quality indicators. The investigators found that improving quality on three cancer screening measures (cervical, breast, and colon) might save lives, but it will not save money. Results were presented at the 2012 American Society of Clinical Oncology Annual Meeting. View the abstract at the ASCO Annual Meeting website ; the poster is available for download here.